UN&UP’s Transformational CorBot™ Electrophysiology System was Awarded Participation into the Prestigious C3i Program by the NIBIB, NHLBI, and Coulter Foundation

C3i stands for Concept to Clinic: Commercializing Innovation, which was established in 2014 by the NIBIB and the Wallace H. Coulter Foundation to provide medical innovators with the specialized business frameworks and essential tools for successful translation of biomedical technologies from the lab (concept) to the market (clinic).

UN&UP’s CorBot™ technology is a novel robotic system being developed by the team that invented Stereotaxis’ commercial electrophysiology system, whose technology is now more than 20 years old. Thanks to several breakthroughs sponsored by multiple NIH SBIR awards, CorBot™ is poised to transform standard care for patients suffering from arrythmias using a more effective and safer robotic system that is 50X smaller than Stereotaxis’ system. Because new x-ray systems, room renovation,
and magnetic shielding are not required, CorBot™ promises to provide superior care at a price 10X lower.